Profile data is unavailable for this security.
About the company
PT Pyridam Farma Tbk is an Indonesia-based company, which is engaged in the production, development, and/or trade of pharmaceuticals, as well as the trade of medical devices and cosmetics. The Company’s segments include Pharmaceutical Products, Esthetic and Toll Manufacturing Services and Medical Device Products. The Company’s product portfolio includes Consumer Health, Pyfaesthetic, Sanitizer & Antiseptic, Medical Support, Sterile & Injection, Biomedilab, Betadine Group & Guardix. The Consumer Health category provides over-the-counter drugs, including supplements and other preventive products, along with energy drinks and healthy ready-to-drink products. Its Pyfaesthetic category includes products, such as Aileene 17, CO2 Carboxy Gel, EFI Cream, Yalode Instant Eye Lifting, Ep+derm Plus Mask, CO2 Facial & Neck Sheet, among others. Its Biomedilab provides various medical equipment and tools for hospitals and laboratories which have been clinically tested.
- Revenue in IDR (TTM)1.34tn
- Net income in IDR-253.95bn
- Incorporated1977
- Employees1.33k
- LocationPyridam Farma Tbk PTJalan Kemandoran 8 No 16JAKARTA 12920IndonesiaIDN
- Phone+62 2 153690112
- Fax+62 215329049
- Websitehttps://www.pyfa.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LifeVantage Corp | 3.12tn | 65.83bn | 2.62tn | 217.00 | 41.23 | 5.93 | 21.71 | 0.8409 | 0.3192 | 0.3192 | 15.27 | 2.22 | 3.06 | 2.50 | 71.64 | 903,290.30 | 6.46 | 9.95 | 10.17 | 15.55 | 79.21 | 81.45 | 2.11 | 3.08 | 0.9923 | 559.36 | 0.00 | 26.95 | -6.20 | -2.40 | 15.63 | -16.94 | -2.18 | -- |
| Hyloris Pharmaceuticals SA | 84.74bn | -204.02bn | 2.71tn | 24.00 | -- | 4.69 | -- | 31.97 | -0.4281 | -0.4281 | 0.1789 | 1.24 | 0.0989 | -- | 1.19 | -- | -23.82 | -22.79 | -28.07 | -28.09 | 96.95 | 92.05 | -240.77 | -815.53 | -- | -- | 0.0516 | -- | 131.89 | 87.11 | -29.18 | -- | 89.12 | -- |
| Zota Health Care Ltd | 414.89bn | -65.36bn | 2.74tn | 445.00 | -- | 9.14 | -- | 6.60 | -13.20 | -13.20 | 84.28 | 59.92 | 0.8794 | 2.11 | 7.20 | 4,947,045.00 | -13.89 | -1.38 | -17.57 | -1.85 | 51.96 | 35.95 | -15.79 | -1.33 | 0.8357 | -3.46 | 0.3966 | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Sinphar Pharmaceutical Co Ltd | 1.49tn | 162.78bn | 2.76tn | 984.00 | 16.95 | 1.77 | 9.84 | 1.85 | 1.83 | 1.83 | 16.78 | 17.56 | 0.4901 | 2.34 | 6.85 | -- | 5.29 | -0.0147 | 6.91 | -0.0203 | 38.51 | 37.49 | 10.80 | -0.0344 | 1.58 | 19.25 | 0.3435 | 79.70 | 3.72 | 5.98 | 67.01 | 111.88 | 3.31 | 60.95 |
| Scpharmaceuticals Inc | 482.18bn | -1.28tn | 2.76tn | 135.00 | -- | 5.64 | -- | 5.72 | -1.91 | -1.91 | 0.7417 | 0.6137 | 0.262 | 0.7268 | 4.52 | 224,281.50 | -69.31 | -38.23 | -78.18 | -42.31 | 69.72 | -- | -264.60 | -1,360.16 | 6.89 | -8.42 | 0.6246 | -- | -- | -- | -48.79 | -- | -- | -- |
| Cenra Inc | 4.37tn | 181.84bn | 2.77tn | 1.40k | 25.41 | 0.756 | 7.83 | 0.6338 | 1.50 | 1.50 | 34.28 | 50.26 | 0.7106 | 2.15 | 5.73 | -- | 2.97 | 3.69 | 4.29 | 4.96 | 37.10 | 36.56 | 4.18 | 5.50 | 0.7054 | -- | 0.2976 | 52.77 | 1.40 | 2.50 | -32.51 | -2.72 | 3.57 | -8.97 |
| T Man Pharmaceutical PCL | 997.42bn | 198.73bn | 2.84tn | -- | 14.31 | 11.78 | 24.90 | 2.85 | 1.08 | 1.08 | 5.44 | 1.32 | 0.875 | 2.14 | 4.01 | -- | 17.43 | -- | 39.47 | -- | 47.56 | -- | 19.92 | -- | 0.366 | 40.92 | 0.3609 | -- | -2.20 | -- | -8.82 | -- | -- | -- |
| Formosa Pharmaceuticals Inc | 67.24bn | -98.12bn | 2.87tn | -- | -- | 3.66 | -- | 42.72 | -1.49 | -1.49 | 1.02 | 10.62 | -- | -- | -- | -- | -- | -40.34 | -- | -44.21 | 84.63 | -- | -145.95 | -2,488.28 | -- | -- | 0.0167 | -- | 2,270.49 | -- | 20.75 | -- | -42.98 | -- |
| Mediwound Ltd | 320.75bn | -318.07bn | 2.88tn | 100.00 | -- | 8.71 | -- | 8.98 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
| Pyridam Farma Tbk PT | 1.34tn | -253.95bn | 2.92tn | 1.33k | -- | 2.44 | -- | 2.17 | -49.15 | -49.15 | 195.71 | 106.69 | 0.3606 | 2.65 | 3.33 | 1,126,088,000.00 | -6.82 | 6.31 | -10.49 | 8.07 | 27.38 | 42.56 | -18.91 | 8.83 | 0.5175 | -1.14 | 0.764 | -- | -1.87 | 22.89 | -130.96 | -- | 2.93 | -- |
